Effectiveness of seasonal influenza vaccines in the United States during a season with circulation of all three vaccine strains

Clinical Infectious Diseases

Volumn 55, Issue 7, 2012, Pages 951-959

  Treanor, John J ^a   Talbot, H Keipp ^b   Ohmit, Suzanne E ^e   Coleman, Laura A ^f   Thompson, Mark G ^g   Cheng, Po Yung ^g   Petrie, Joshua G ^e   Lofthus, Geraldine ^a   Meece, Jennifer K ^f   Williams, John V ^b,c   Berman, Lashondra ^g   Breese Hall, Caroline ^a   Monto, Arnold S ^e   Griffin, Marie R ^b,d   Belongia, Edward ^f   Shay, David K ^g  

^a UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

^b Department of Medicine and Pediatrics ^*  (United States)

^c VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d VETERANS AFFAIRS MEDICAL CENTER   (United States)

^e UNIVERSITY OF MICHIGAN SCHOOL OF PUBLIC HEALTH   (United States)

^f MARSHFIELD CLINIC   (United States)

^g CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INFLUENZA VACCINE;

ADOLESCENT; ADULT; AGED; ARTICLE; CASE CONTROL STUDY; CHILD; CIRCULATION; CONTROLLED STUDY; DISEASE DURATION; DRUG EFFICACY; FEMALE; HUMAN; INFANT; INFLUENZA A (H1N1); INFLUENZA A (H3N2); INFLUENZA B; INFLUENZA VACCINATION; MAJOR CLINICAL STUDY; MALE; PRESCHOOL CHILD; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SCHOOL CHILD; SEASONAL INFLUENZA; SEASONAL VARIATION;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; INFANT; INFLUENZA VACCINES; INFLUENZA, HUMAN; MALE; MIDDLE AGED; TREATMENT OUTCOME; UNITED STATES; YOUNG ADULT;

EID: 84864940036     PISSN: 10584838     EISSN: 15376591     Source Type: Journal    
DOI: 10.1093/cid/cis574     Document Type: Article

References (21)

1. Orenstein EW, de Serres G, Haber MJ, et al. Methodologic issues regarding the use of three observational study designs to assess influenza vaccine effectiveness. Int J Epidemiol 2007; 36:623-31. (Pubitemid 47244566)
2. Griffin MR, Monto AS, Belongia EA, et al. Effectiveness of non-adjuvanted pandemic influenza A vaccines for preventing pandemic influenza acute respiratory illness visits in 4 U.S. communities. PLoS One 2011; 6:e23085.
3. Centers for Disease Control and Prevention. Prevention and control of influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2010. MMWR Morb Mortal Wkly Rep 2010; 59:1-62.
4. Irving SA, Donahue JG, Shay DK, Ellis-Coyle TL, Belongia EA. Evaluation of self-reported and registry-based influena vaccination status in a Wisconsin cohort. Vaccine 2009; 27:6543-9.
5. Kendal A, Pereira M, Skehel J. Hemagglutination-inhibtion: concepts and procedures for laboratory-based influenza surveillance. 1982. US Department of Health and Human Services, Atlanta GA.
6. Centers for Disease Control and Prevention. Prevention and control of influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2011. MMWR Morb Mortal Wkly Rep 2011; 60:1128-32.
7. Belongia EA, Kieke BA, Donahue JG, et al. Effectiveness of inactivated influenza vaccines varied substantially with antigenic match from the 2004-2005 season to the 2006-2007 season. J Infect Dis 2009; 199:159-67.
8. Belongia E, Kieke B, Coleman L, et al. Interim within-season estimate of the effectiveness of trivalent inactivated influenza vaccine\- Marshfield, Wisconsin, 2007-2008 influenza season. MMWR Morb Mortal Wkly Rep 2008; 57:393-8.
9. Skowronski DM, De Serres G, Dickinson J, et al. Component-specific effectiveness of trivalent influenza vaccine as monitored through a sentinel surveillance network in Canada, 2006-2007. J Infect Dis 2009; 199:160-79.
10. Frey S, Vesikari T, Szymczakiewicz-Multanowska A, et al. Clinical efficacy of cell culture-derived and egg-derived inactivated subunit influenza vaccines in healthy adults. Clin Infect Dis 2010; 51: 997-1004.
11. Monto AS, Ohmit SE, Petrie JG, et al. Comparative efficacy of inactivated and live attenuated influenza vaccines. N Engl J Med 2009; 361:1260-7.
12. Ohmit SE, Victor JC, Rotthoff JR, et al. Prevention of antigenically drifted influenza by inactivated and live attenuated vaccines. N Engl J Med 2006; 355:2513-22. (Pubitemid 44917499)
13. Beran J, Wertzova V, Honegr K, et al. Challenge of conducting a placebo-controlled randomized efficacy study for influenza vaccine in a season with low attack rate and a mismatched vaccine B strain: a concrete example. BMC Infect Dis 2009; 9:2.
14. Jackson L, Gaglani M, Keyserling H, et al. Safety, efficacy, and immu-nogenicity of an inactivated influenza vaccine in healthy adults: a randomized, placebo-controlled trial over two influenza seasons. BMC Infect Dis 2010; 10:71-7.
15. Osterholm MT, Kelley NS, Sommer A, Belongia E. Influenza vaccine efficacy and effectiveness: a new look at the evidence. Lancet Infect Dis 2012; 12:36-44.
16. de Villiers PJT, Steele AD, Hiemstra LA, et al. Efficacy and safety of a live attenuated influenza vaccine in adults 60 years of age and older. Vaccine 2009; 28:228-34.
17. Belshe RB, Mendelman PM, Treanor J, et al. The efficacy of live attenuated cold-adapted trivalent, intranasal influenzavirus vaccine in children. N Engl J Med 1998; 358:1405-12. (Pubitemid 28221981)
18. Belshe RB, Edwards KM, Vesikari T, et al. Live attenuated versus inactivated influenza vaccine in infants and young children. N Engl J Med 2007; 356:685-96.
19. Falsey AR, Treanor JJ, Tornieporth N, Capellan J, Gorse GJ. Superior immunogenicity of high dose influenza vaccine compared with standard influenza vaccine in adults >65 years of age: a randomized double-blinded controlled phase 3 trial. J Infect Dis 2008; 200: 172-80.
20. Vesikari T, Knuf M, Wutzler P, et al. Oil-in-water emulsion adjuvant with influenza vaccine in young children. N Engl J Med 2011; 365:1406-16.
21. Loeb M, Russell ML, Moss L, et al. Effect of influenza vaccination of children on infection rates in Hutterite communities: a randomized trial. JAMA 2010; 303:943-50.